Jaguar Health, Inc.
NASDAQ: JAGX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lisa A. Conte
- Employees
- 49
- Headquarters
- San Francisco, United States
- IPO year
- 2015
- Market cap
- $178.6K
- Website
- https://jaguar.health
Loading JAGX…
Loading profile data…Frequently asked questions about JAGX
What does Jaguar Health, Inc. (JAGX) do?
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company market...
Where does JAGX trade?
Jaguar Health, Inc. (JAGX) trades on the NASDAQ Capital Market.
What sector is JAGX in?
Jaguar Health, Inc. (JAGX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jaguar Health, Inc.?
Lisa A. Conte is the chief executive officer of Jaguar Health, Inc. (JAGX).
Where is Jaguar Health, Inc. headquartered?
Jaguar Health, Inc. is headquartered in United States.
Does JAGX pay a dividend?
Jaguar Health, Inc. (JAGX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did JAGX go public?
Jaguar Health, Inc. (JAGX) completed its initial public offering in 2015.